All In Biotech

Drug Trial Radar · NCT06765668

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

Open-Label Phase 4 Study of CREXONT® (Carbidopa and Levodopa) Extended Release Capsules in Parkinson's Disease Patients

Last checked: Nov 20, 2026Latest source record: Aug 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

220

Planned (sponsor's estimate)

Start

Feb 12, 2025

Primary completion

Nov 2025

Study completion Aug 6, 2026

Sponsor

Lead sponsor
Impax Laboratories, LLCIndustry
Sponsor type
Industry
Collaborators
Amneal Pharmaceuticals, LLC
First posted
Jan 9, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this study is to evaluate efficacy and safety of CREXONT under real world conditions in participants with Parkinson disease (PD).

Conditions

  • Parkinson Disease

Interventions

  • CREXONT ERDrug

    CREXONT ER capsule.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in "GOOD ON" time per the Parkinson's Disease Diary to Day 42Time frame: Baseline, Day 42

Locations

27 sites in 1 country. Site status is shown where the registry gives one.

  • Barrow Neurological Institute

    Phoenix, Arizona · Not yet recruiting

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas · Recruiting

  • Parkinson's Research Centers of America - Orange County

    Aliso Viejo, California · Recruiting

  • Parkinson's Research Centers of America - Palo Alto

    Palo Alto, California · Recruiting

  • Visionary Investigators Network

    Aventura, Florida · Recruiting

  • Parkinsons Disease and Movement Disorders Center of Boca Raton

    Boca Raton, Florida · Recruiting

  • Univesity of Miami - Miller School of Medicine

    Boca Raton, Florida · Recruiting

  • University of Miami

    Miami, Florida · Recruiting

  • N1 Research LLC

    Orlando, Florida · Recruiting

  • USF Parkinson's Disease and Movement Disorders Center

    Tampa, Florida · Recruiting

  • Central DuPage Hospital - Movement Disorders Center

    Winfield, Illinois · Not yet recruiting

  • University of Kansas Medical Center

    Kansas City, Kansas · Recruiting

  • Quest Research Institute

    Farmington Hills, Michigan · Recruiting

  • Cleveland Clinic Lou Ruvo Center for Brain Health

    Las Vegas, Nevada · Not yet recruiting

  • Parkinson's Research Centers of America - Long Island

    Commack, New York · Recruiting

  • Atrium Health Wake Forest Baptist Adult Neurology - Janeway Tower

    Winston-Salem, North Carolina · Recruiting

  • NeuroScience Research Center, LLC

    Canton, Ohio · Recruiting

  • University of Cincinnati

    Cincinnati, Ohio · Recruiting

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio · Recruiting

  • The Movement Disorder Clinic of Oklahoma

    Tulsa, Oklahoma · Recruiting

  • Neurology Consultants of Dallas, PA

    Dallas, Texas · Recruiting

  • Texas Movement Disorder Specialists, PLLC

    Georgetown, Texas · Recruiting

  • Icahn School of Medicine at Mount Sinai

    Houston, Texas · Not yet recruiting

  • The University of Texas Health Science Center at Houston- McGovern Medical School

    Houston, Texas · Recruiting

  • Inova Neurology

    Fairfax, Virginia · Recruiting

  • VCU Parkinsons Disease and Movement Disorders Center

    Henrico, Virginia · Recruiting

  • MedStar Georgetown University Hospital Department of Neurology

    McLean, Virginia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.